Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapies.
作者信息
Simonsson Otto, Goldberg Simon B, Hendricks Peter S
机构信息
Department of Neurobiology, Care Sciences, and Society, Karolinska Institute, Sweden.
Department of Counseling Psychology, University of Wisconsin-Madison, Madison, WI, USA.
出版信息
J Psychopharmacol. 2025 May;39(5):434-435. doi: 10.1177/02698811241292944. Epub 2024 Oct 29.
Abstract
摘要
相似文献
1
Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapies.进入未知领域：描绘迷幻辅助疗法中不良事件的情况
J Psychopharmacol. 2025 May;39(5):434-435. doi: 10.1177/02698811241292944. Epub 2024 Oct 29.
2
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
3
Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.迷幻精神病学与联络会诊精神科医生：入门指南。
J Acad Consult Liaison Psychiatry. 2021 Jul-Aug;62(4):460-471. doi: 10.1016/j.jaclp.2020.12.011. Epub 2021 Jan 21.
4
Commentary: A framework for assessment of adverse events in psychedelic research.
J Psychopharmacol. 2025 May;39(5):431-433. doi: 10.1177/02698811241309623. Epub 2024 Dec 29.
5
Psychedelic-assisted psychotherapy: The need to monitor adverse events.迷幻剂辅助心理治疗：监测不良事件的必要性。
J Psychopharmacol. 2025 Sep;39(9):896-899. doi: 10.1177/02698811251340929. Epub 2025 May 21.
6
Psychedelic-assisted therapies: The past, and the need to move forward responsibly.迷幻辅助疗法：过去，以及负责任地向前推进的必要性。
Int J Drug Policy. 2019 Aug;70:94-98. doi: 10.1016/j.drugpo.2019.05.019. Epub 2019 May 25.
7
Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users.自然主义迷幻药使用者样本中的迷幻疗法治疗师性行为不端及其他不良经历
Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):41-47. doi: 10.1089/psymed.2024.0011. eCollection 2025 Mar.
8
Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.绘制精神类辅助治疗严重疾病患者的研究议程图。
J Palliat Med. 2021 Nov;24(11):1657-1666. doi: 10.1089/jpm.2020.0764. Epub 2021 Apr 13.
9
Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.精神科中使用迷幻剂的伦理和实践考虑。
Psychiatr Serv. 2023 Aug 1;74(8):838-846. doi: 10.1176/appi.ps.20220525. Epub 2023 Mar 29.
10
Medical student attitudes and perceptions of psychedelic-assisted therapies.医学生对迷幻剂辅助疗法的态度和看法。
Front Psychiatry. 2023 Jun 27;14:1190507. doi: 10.3389/fpsyt.2023.1190507. eCollection 2023.
引用本文的文献
1
Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors.使用迷幻剂对冥想练习有益吗？审视个体、迷幻剂及与冥想相关的因素。
PLoS One. 2025 Feb 12;20(2):e0310160. doi: 10.1371/journal.pone.0310160. eCollection 2025.
本文引用的文献
1
A framework for assessment of adverse events occurring in psychedelic-assisted therapies.用于评估迷幻辅助治疗中发生的不良事件的框架。
J Psychopharmacol. 2024 Aug;38(8):690-700. doi: 10.1177/02698811241265756. Epub 2024 Jul 31.
2
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.在一项用于治疗重度抑郁症的迷幻蘑菇辅助治疗试验中，研究参与者和干预促进者之间的治疗联盟与急性效应和临床结果相关。
PLoS One. 2024 Mar 14;19(3):e0300501. doi: 10.1371/journal.pone.0300501. eCollection 2024.
3
Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies.重视迷幻辅助治疗中的精神、存在主义、宗教和神学因素。
JAMA Psychiatry. 2023 Jul 1;80(7):743-749. doi: 10.1001/jamapsychiatry.2023.1554.
4
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.使用血清素能致幻剂和 MDMA 进行临床治疗的不良事件：一项混合方法系统评价。
J Psychopharmacol. 2022 Oct;36(10):1100-1117. doi: 10.1177/02698811221116926. Epub 2022 Aug 26.
5
The Current Status of Psychedelics in Psychiatry.精神药物在精神病学中的现状
JAMA Psychiatry. 2021 Feb 1;78(2):121-122. doi: 10.1001/jamapsychiatry.2020.2171.
6
Placebo and Nocebo Effects.安慰剂和反安慰剂效应。
N Engl J Med. 2020 Feb 6;382(6):554-561. doi: 10.1056/NEJMra1907805.
7
Minimizing Drug Adverse Events by Informing About the Nocebo Effect-An Experimental Study.通过告知反安慰剂效应来尽量减少药物不良事件——一项实验研究
Front Psychiatry. 2019 Jul 25;10:504. doi: 10.3389/fpsyt.2019.00504. eCollection 2019.
8
LSD enhances suggestibility in healthy volunteers.麦角酸二乙酰胺（LSD）会增强健康志愿者的受暗示性。
Psychopharmacology (Berl). 2015 Feb;232(4):785-94. doi: 10.1007/s00213-014-3714-z. Epub 2014 Sep 23.
Zotero 插件